It has been reported that FOXO1 mutation is associated with inferior prognosis [60], refractory and relapsed GCB-DLBCL [64], as well as correlations with TP53 and BCL2 mutation [64, 65]. Here, TP53 is linked to diffuse large B-cell lymphoma.